TearClear OIS Article
TearClear aims to be the premier specialty pharmaceutical company assuring reliable delivery of preservative-free ophthalmic drugs from preserved multi-dose solutions.
Visionary Ventures
Life sciences venture capital fund investing in ophthalmology and medical aesthetics.
